Aminoacyl-tRNA Synthetase Inhibitors as Potent and Synergistic Immunosuppressants

The aminoacyl-tRNA synthetase family of enzymes is the target of many antibacterials and inhibitors of eukaryotic hyperproliferation. In screening analogues of 5′-O-(N-l-aminoacyl)-sulfamoyladenosine containing all 20 proteinogenic amino acids, we found these compounds to have potent immunosuppressi...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Journal of medicinal chemistry 2008-05, Vol.51 (10), p.3020-3029
Hauptverfasser: Van de Vijver, Pieter, Ostrowski, Tomasz, Sproat, Brian, Goebels, Jozef, Rutgeerts, Omer, Van Aerschot, Arthur, Waer, Mark, Herdewijn, Piet
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 3029
container_issue 10
container_start_page 3020
container_title Journal of medicinal chemistry
container_volume 51
creator Van de Vijver, Pieter
Ostrowski, Tomasz
Sproat, Brian
Goebels, Jozef
Rutgeerts, Omer
Van Aerschot, Arthur
Waer, Mark
Herdewijn, Piet
description The aminoacyl-tRNA synthetase family of enzymes is the target of many antibacterials and inhibitors of eukaryotic hyperproliferation. In screening analogues of 5′-O-(N-l-aminoacyl)-sulfamoyladenosine containing all 20 proteinogenic amino acids, we found these compounds to have potent immunosuppressive activity. Also, we found that combinations of these compounds inhibited the immune response synergistically. Based on these data, analogues with modifications at the aminoacyl and ribose moieties were designed and evaluated, and several of these showed high immunosuppressive potency, with one compound having an IC50 of 80 nM, when tested in a cellular mixed lymphocyte reaction assay. Apart from showing the potential of aminoacyl-tRNA synthetase inhibitors as immunosuppressants, the current study also provides arguments for careful evaluation of the immunosuppressive activity of developmental antibacterials that target these enzymes.
doi_str_mv 10.1021/jm8000746
format Article
fullrecord <record><control><sourceid>istex_cross</sourceid><recordid>TN_cdi_crossref_primary_10_1021_jm8000746</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>ark_67375_TPS_KCT84NQW_M</sourcerecordid><originalsourceid>FETCH-LOGICAL-a447t-93fe08ddf6bcbb88642733055f612e816239fa953394c3e5f95b027256b11b13</originalsourceid><addsrcrecordid>eNpt0LtOwzAUBmALgWi5DLwAysLAEPAtjjNWFZeKUloaidGyU5umNE5kOxJ9e1K1ahemM5xP5_IDcIPgA4IYPa4qDiFMKTsBfZRgGFMO6SnoQ4hxjBkmPXDh_aozBGFyDnqIU8IznvbBbFCVtpbFZh2Hz8kgmm9sWOogvY5GdlmqMtTOR9JH0zpoGyJpF1uj3XfpQ1lEo6pqbe3bpnHae2mDvwJnRq69vt7XS5A_P-XD13j88TIaDsaxpDQNcUaMhnyxMEwVSnHOKE4JgUliGMKao-7qzMgsISSjBdGJyRIFcYoTphBSiFyC-93YwtXeO21E48pKuo1AUGxTEYdUOnu7s02rKr04yn0MHbjbA-kLuTZO2qL0B4choRll26XxznXP699DX7ofwVKSJiKfzsXbMOd0MvsS78e5svBiVbfOdon8c-AfhlaEfg</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>Aminoacyl-tRNA Synthetase Inhibitors as Potent and Synergistic Immunosuppressants</title><source>MEDLINE</source><source>American Chemical Society Journals</source><creator>Van de Vijver, Pieter ; Ostrowski, Tomasz ; Sproat, Brian ; Goebels, Jozef ; Rutgeerts, Omer ; Van Aerschot, Arthur ; Waer, Mark ; Herdewijn, Piet</creator><creatorcontrib>Van de Vijver, Pieter ; Ostrowski, Tomasz ; Sproat, Brian ; Goebels, Jozef ; Rutgeerts, Omer ; Van Aerschot, Arthur ; Waer, Mark ; Herdewijn, Piet</creatorcontrib><description>The aminoacyl-tRNA synthetase family of enzymes is the target of many antibacterials and inhibitors of eukaryotic hyperproliferation. In screening analogues of 5′-O-(N-l-aminoacyl)-sulfamoyladenosine containing all 20 proteinogenic amino acids, we found these compounds to have potent immunosuppressive activity. Also, we found that combinations of these compounds inhibited the immune response synergistically. Based on these data, analogues with modifications at the aminoacyl and ribose moieties were designed and evaluated, and several of these showed high immunosuppressive potency, with one compound having an IC50 of 80 nM, when tested in a cellular mixed lymphocyte reaction assay. Apart from showing the potential of aminoacyl-tRNA synthetase inhibitors as immunosuppressants, the current study also provides arguments for careful evaluation of the immunosuppressive activity of developmental antibacterials that target these enzymes.</description><identifier>ISSN: 0022-2623</identifier><identifier>EISSN: 1520-4804</identifier><identifier>DOI: 10.1021/jm8000746</identifier><identifier>PMID: 18438987</identifier><identifier>CODEN: JMCMAR</identifier><language>eng</language><publisher>Washington, DC: American Chemical Society</publisher><subject>Adenosine - analogs &amp; derivatives ; Adenosine - chemical synthesis ; Adenosine - pharmacology ; Amino Acids - chemical synthesis ; Amino Acids - pharmacology ; Amino Acyl-tRNA Synthetases - antagonists &amp; inhibitors ; Antibacterial agents ; Antibiotics. Antiinfectious agents. Antiparasitic agents ; Biological and medical sciences ; Cells, Cultured ; Drug Synergism ; Humans ; Immunomodulators ; Immunosuppressive Agents - chemical synthesis ; Immunosuppressive Agents - chemistry ; Immunosuppressive Agents - pharmacology ; Leukocytes, Mononuclear - drug effects ; Leukocytes, Mononuclear - immunology ; Lymphocyte Culture Test, Mixed ; Medical sciences ; Pharmacology. Drug treatments ; Structure-Activity Relationship</subject><ispartof>Journal of medicinal chemistry, 2008-05, Vol.51 (10), p.3020-3029</ispartof><rights>Copyright © 2008 American Chemical Society</rights><rights>2008 INIST-CNRS</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-a447t-93fe08ddf6bcbb88642733055f612e816239fa953394c3e5f95b027256b11b13</citedby><cites>FETCH-LOGICAL-a447t-93fe08ddf6bcbb88642733055f612e816239fa953394c3e5f95b027256b11b13</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://pubs.acs.org/doi/pdf/10.1021/jm8000746$$EPDF$$P50$$Gacs$$H</linktopdf><linktohtml>$$Uhttps://pubs.acs.org/doi/10.1021/jm8000746$$EHTML$$P50$$Gacs$$H</linktohtml><link.rule.ids>314,780,784,2765,27076,27924,27925,56738,56788</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&amp;idt=20349461$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/18438987$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Van de Vijver, Pieter</creatorcontrib><creatorcontrib>Ostrowski, Tomasz</creatorcontrib><creatorcontrib>Sproat, Brian</creatorcontrib><creatorcontrib>Goebels, Jozef</creatorcontrib><creatorcontrib>Rutgeerts, Omer</creatorcontrib><creatorcontrib>Van Aerschot, Arthur</creatorcontrib><creatorcontrib>Waer, Mark</creatorcontrib><creatorcontrib>Herdewijn, Piet</creatorcontrib><title>Aminoacyl-tRNA Synthetase Inhibitors as Potent and Synergistic Immunosuppressants</title><title>Journal of medicinal chemistry</title><addtitle>J. Med. Chem</addtitle><description>The aminoacyl-tRNA synthetase family of enzymes is the target of many antibacterials and inhibitors of eukaryotic hyperproliferation. In screening analogues of 5′-O-(N-l-aminoacyl)-sulfamoyladenosine containing all 20 proteinogenic amino acids, we found these compounds to have potent immunosuppressive activity. Also, we found that combinations of these compounds inhibited the immune response synergistically. Based on these data, analogues with modifications at the aminoacyl and ribose moieties were designed and evaluated, and several of these showed high immunosuppressive potency, with one compound having an IC50 of 80 nM, when tested in a cellular mixed lymphocyte reaction assay. Apart from showing the potential of aminoacyl-tRNA synthetase inhibitors as immunosuppressants, the current study also provides arguments for careful evaluation of the immunosuppressive activity of developmental antibacterials that target these enzymes.</description><subject>Adenosine - analogs &amp; derivatives</subject><subject>Adenosine - chemical synthesis</subject><subject>Adenosine - pharmacology</subject><subject>Amino Acids - chemical synthesis</subject><subject>Amino Acids - pharmacology</subject><subject>Amino Acyl-tRNA Synthetases - antagonists &amp; inhibitors</subject><subject>Antibacterial agents</subject><subject>Antibiotics. Antiinfectious agents. Antiparasitic agents</subject><subject>Biological and medical sciences</subject><subject>Cells, Cultured</subject><subject>Drug Synergism</subject><subject>Humans</subject><subject>Immunomodulators</subject><subject>Immunosuppressive Agents - chemical synthesis</subject><subject>Immunosuppressive Agents - chemistry</subject><subject>Immunosuppressive Agents - pharmacology</subject><subject>Leukocytes, Mononuclear - drug effects</subject><subject>Leukocytes, Mononuclear - immunology</subject><subject>Lymphocyte Culture Test, Mixed</subject><subject>Medical sciences</subject><subject>Pharmacology. Drug treatments</subject><subject>Structure-Activity Relationship</subject><issn>0022-2623</issn><issn>1520-4804</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2008</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNpt0LtOwzAUBmALgWi5DLwAysLAEPAtjjNWFZeKUloaidGyU5umNE5kOxJ9e1K1ahemM5xP5_IDcIPgA4IYPa4qDiFMKTsBfZRgGFMO6SnoQ4hxjBkmPXDh_aozBGFyDnqIU8IznvbBbFCVtpbFZh2Hz8kgmm9sWOogvY5GdlmqMtTOR9JH0zpoGyJpF1uj3XfpQ1lEo6pqbe3bpnHae2mDvwJnRq69vt7XS5A_P-XD13j88TIaDsaxpDQNcUaMhnyxMEwVSnHOKE4JgUliGMKao-7qzMgsISSjBdGJyRIFcYoTphBSiFyC-93YwtXeO21E48pKuo1AUGxTEYdUOnu7s02rKr04yn0MHbjbA-kLuTZO2qL0B4choRll26XxznXP699DX7ofwVKSJiKfzsXbMOd0MvsS78e5svBiVbfOdon8c-AfhlaEfg</recordid><startdate>20080522</startdate><enddate>20080522</enddate><creator>Van de Vijver, Pieter</creator><creator>Ostrowski, Tomasz</creator><creator>Sproat, Brian</creator><creator>Goebels, Jozef</creator><creator>Rutgeerts, Omer</creator><creator>Van Aerschot, Arthur</creator><creator>Waer, Mark</creator><creator>Herdewijn, Piet</creator><general>American Chemical Society</general><scope>BSCLL</scope><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope></search><sort><creationdate>20080522</creationdate><title>Aminoacyl-tRNA Synthetase Inhibitors as Potent and Synergistic Immunosuppressants</title><author>Van de Vijver, Pieter ; Ostrowski, Tomasz ; Sproat, Brian ; Goebels, Jozef ; Rutgeerts, Omer ; Van Aerschot, Arthur ; Waer, Mark ; Herdewijn, Piet</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-a447t-93fe08ddf6bcbb88642733055f612e816239fa953394c3e5f95b027256b11b13</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2008</creationdate><topic>Adenosine - analogs &amp; derivatives</topic><topic>Adenosine - chemical synthesis</topic><topic>Adenosine - pharmacology</topic><topic>Amino Acids - chemical synthesis</topic><topic>Amino Acids - pharmacology</topic><topic>Amino Acyl-tRNA Synthetases - antagonists &amp; inhibitors</topic><topic>Antibacterial agents</topic><topic>Antibiotics. Antiinfectious agents. Antiparasitic agents</topic><topic>Biological and medical sciences</topic><topic>Cells, Cultured</topic><topic>Drug Synergism</topic><topic>Humans</topic><topic>Immunomodulators</topic><topic>Immunosuppressive Agents - chemical synthesis</topic><topic>Immunosuppressive Agents - chemistry</topic><topic>Immunosuppressive Agents - pharmacology</topic><topic>Leukocytes, Mononuclear - drug effects</topic><topic>Leukocytes, Mononuclear - immunology</topic><topic>Lymphocyte Culture Test, Mixed</topic><topic>Medical sciences</topic><topic>Pharmacology. Drug treatments</topic><topic>Structure-Activity Relationship</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Van de Vijver, Pieter</creatorcontrib><creatorcontrib>Ostrowski, Tomasz</creatorcontrib><creatorcontrib>Sproat, Brian</creatorcontrib><creatorcontrib>Goebels, Jozef</creatorcontrib><creatorcontrib>Rutgeerts, Omer</creatorcontrib><creatorcontrib>Van Aerschot, Arthur</creatorcontrib><creatorcontrib>Waer, Mark</creatorcontrib><creatorcontrib>Herdewijn, Piet</creatorcontrib><collection>Istex</collection><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><jtitle>Journal of medicinal chemistry</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Van de Vijver, Pieter</au><au>Ostrowski, Tomasz</au><au>Sproat, Brian</au><au>Goebels, Jozef</au><au>Rutgeerts, Omer</au><au>Van Aerschot, Arthur</au><au>Waer, Mark</au><au>Herdewijn, Piet</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Aminoacyl-tRNA Synthetase Inhibitors as Potent and Synergistic Immunosuppressants</atitle><jtitle>Journal of medicinal chemistry</jtitle><addtitle>J. Med. Chem</addtitle><date>2008-05-22</date><risdate>2008</risdate><volume>51</volume><issue>10</issue><spage>3020</spage><epage>3029</epage><pages>3020-3029</pages><issn>0022-2623</issn><eissn>1520-4804</eissn><coden>JMCMAR</coden><abstract>The aminoacyl-tRNA synthetase family of enzymes is the target of many antibacterials and inhibitors of eukaryotic hyperproliferation. In screening analogues of 5′-O-(N-l-aminoacyl)-sulfamoyladenosine containing all 20 proteinogenic amino acids, we found these compounds to have potent immunosuppressive activity. Also, we found that combinations of these compounds inhibited the immune response synergistically. Based on these data, analogues with modifications at the aminoacyl and ribose moieties were designed and evaluated, and several of these showed high immunosuppressive potency, with one compound having an IC50 of 80 nM, when tested in a cellular mixed lymphocyte reaction assay. Apart from showing the potential of aminoacyl-tRNA synthetase inhibitors as immunosuppressants, the current study also provides arguments for careful evaluation of the immunosuppressive activity of developmental antibacterials that target these enzymes.</abstract><cop>Washington, DC</cop><pub>American Chemical Society</pub><pmid>18438987</pmid><doi>10.1021/jm8000746</doi><tpages>10</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0022-2623
ispartof Journal of medicinal chemistry, 2008-05, Vol.51 (10), p.3020-3029
issn 0022-2623
1520-4804
language eng
recordid cdi_crossref_primary_10_1021_jm8000746
source MEDLINE; American Chemical Society Journals
subjects Adenosine - analogs & derivatives
Adenosine - chemical synthesis
Adenosine - pharmacology
Amino Acids - chemical synthesis
Amino Acids - pharmacology
Amino Acyl-tRNA Synthetases - antagonists & inhibitors
Antibacterial agents
Antibiotics. Antiinfectious agents. Antiparasitic agents
Biological and medical sciences
Cells, Cultured
Drug Synergism
Humans
Immunomodulators
Immunosuppressive Agents - chemical synthesis
Immunosuppressive Agents - chemistry
Immunosuppressive Agents - pharmacology
Leukocytes, Mononuclear - drug effects
Leukocytes, Mononuclear - immunology
Lymphocyte Culture Test, Mixed
Medical sciences
Pharmacology. Drug treatments
Structure-Activity Relationship
title Aminoacyl-tRNA Synthetase Inhibitors as Potent and Synergistic Immunosuppressants
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-01T03%3A06%3A09IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-istex_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Aminoacyl-tRNA%20Synthetase%20Inhibitors%20as%20Potent%20and%20Synergistic%20Immunosuppressants&rft.jtitle=Journal%20of%20medicinal%20chemistry&rft.au=Van%20de%20Vijver,%20Pieter&rft.date=2008-05-22&rft.volume=51&rft.issue=10&rft.spage=3020&rft.epage=3029&rft.pages=3020-3029&rft.issn=0022-2623&rft.eissn=1520-4804&rft.coden=JMCMAR&rft_id=info:doi/10.1021/jm8000746&rft_dat=%3Cistex_cross%3Eark_67375_TPS_KCT84NQW_M%3C/istex_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/18438987&rfr_iscdi=true